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Apoptosis maintains an equilibrium between cell proliferation and cell death. Many
diseases, including cancer, develop because of defects in apoptosis. A known meta-
bolic marker of apoptosis is a notable increase in 1H NMR-observable resonances
associated with lipids stored in lipid droplets. However, standard one-dimensional
NMR experiments allow the quantification of lipid concentration only, without pro-
viding information about physical characteristics such as the size of lipid droplets, vis-
cosity of the cytosol, or cytoskeletal rigidity. This additional information can improve
monitoring of apoptosis-based cancer treatments in intact cells and provide us with
mechanistic insight into why these changes occur.
In this paper, we use high-resolution magic angle spinning (HRMAS) 1H NMR spec-
troscopy to monitor lipid concentrations and apparent diffusion coefficients of
mobile lipid in intact cells treated with the apoptotic agents cisplatin or etoposide.
We also use solution-state NMR spectroscopy to study changes in lipid profiles of
organic solvent cell extracts. Both NMR techniques show an increase in the concen-
tration of lipids but the relative changes are 10 times larger by HRMAS 1H NMR
spectroscopy. Moreover, the apparent diffusion rates of lipids in apoptotic cells mea-
sured by HRMAS 1H NMR spectroscopy decrease significantly as compared with
control cells. Slower diffusion rates of mobile lipids in apoptotic cells correlate well
with the formation of larger lipid droplets as observed by microscopy. We also com-
pared the mean lipid droplet displacement values calculated from the two methods.
Both methods showed shorter displacements of lipid droplets in apoptotic cells. Our
results demonstrate that the NMR-based diffusion experiments on intact cells dis-
criminate between control and apoptotic cells. Apparent diffusion measurements in
conjunction with 1H NMR spectroscopy-derived lipid signals provide a novel means
of following apoptosis in intact cells. This method could have potential application in
enhancing drug discovery by monitoring drug treatments in vitro, particularly for
agents that cause portioning of lipids such as apoptosis.
Abbreviations: ANOVA, analysis of variance; BODIPY, boron dipyrromethene; COSY, correlation spectroscopy; D, diffusion constant [m2s−1]; DMEM, Dulbecco’s modified Eagle’s medium;
DMSO, dimethyl sulfoxide; DOSY, diffusion-ordered spectroscopy; HRMAS NMR, high-resolution magic angle spinning NMR; k, Boltzmann's constant [m2kgs−2K−1]; LD, lipid droplet; MRS,
magnetic resonance spectroscopy; PBS, phosphate buffered saline; PC, principal component; PCA, principal component analysis; r, radius of diffusing particle [m]; SEM, standard error of the
mean; T, temperature [K]; TMS, tetramethylsilane; TSP, trimethylsilylpropanoic acid; v, viscosity [kgm−1s−1]; W4M, Workflow4Metabolomics.
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1 | INTRODUCTION
Lipid droplets (LDs) are cytosolic organelles composed of neutral lipids enclosed within a phospholipid monolayer. In healthy cells they are a
source of energy, hormones, and secondary messengers, and they protect cells from lipotoxicity.1 Abnormal formation of LDs has been associated
with pathologies such as infection, inflammation, cancer and diabetes.2 Numerous studies report that mobile LDs increase in number and size dur-
ing apoptosis, but the cellular processes behind the production of LDs are not well understood.3
Apoptosis, a process often referred to as programmed cell death because of the regulated way in which the cells dies, requires the cell to
maintain cellular energetics. It is a hallmark of cancer, as its impairment or absence leads to accumulation of cells that can become malignant.4
Since many cancer treatments are based on the induction of apoptosis in cancer cells, studying LD formation is useful in monitoring the effective-
ness of cancer therapies.5,6
Two methods commonly used to monitor the formation of LDs are NMR spectroscopy and fluorescence microscopy. NMR spectroscopy has
been widely used to study the effects of apoptotic agents on the metabolic profiles of tissues and cell lines.7–9 In addition, 1H MRS provides a
non-invasive method for assessing tissue responses to cancer treatments in vivo.10 Solution-state 1H NMR spectroscopy on cell or tissue extracts
gives quantitative information on lipid concentration.11,12 In this case, the 1H NMR spectra represent the collective signal from cytosolic LDs, lipids
contained within cell organelles and membrane lipids. However, not all lipids may be extractable, depending on the extraction procedure used.
Visualization of intracellular lipids by fluorescence microscopy is possible by using lipid soluble dyes.13 It provides information on droplet size,
number and localization in intact cells.14 In addition, live microscopy allows the measurement of diffusional mobility. However, several technical
limitations prevent the study of LDs at the molecular level. These include resolution, photobleaching, long acquisition times and selective fluores-
cence labelling.
For in vitro NMR experiments, an increase in the lipid signal observed in 1H NMR spectra has been linked to an increase in LD size as mea-
sured by microscopy.15,16 NMR-based measurements of the diffusion of mobile lipids have also been used to follow the size of LDs.17 in vivo mea-
surements of apparent diffusion rates of mobile lipids in tissues have also been made, but these have not been specifically linked to droplet size
previously.18 Diffusion experiments can be used to probe changes in LD size in intact cells and structural changes in cellular environment, such as
viscosity of the cytosol or fluidity of cytoskeletal structures. Different types of macromolecule account for 20% to 40% of the free organelle vol-
ume of a cell,19 and along with cellular organelles and cell membranes restrict diffusion rates. For example, Griffin and colleagues reported that the
apparent diffusion of intracellular water in endometrial cells was more than seven times slower than the diffusion of extracellular water.20
In MRI, changes in apparent diffusion of water can be a sign of disease and it is a common clinical practice to use diffusion-weighted MRS for
diagnostic purposes.21 Apparent diffusion measurements have also been used to probe LD behaviour ex vivo22 and in vivo.23 However, few stud-
ies have focused on NMR-based diffusion rates of lipids in intact cells,17,20 because of the challenges of achieving the necessary spectral resolu-
tion in these media.
High-resolution magic angle spinning (HRMAS) 1H NMR spectroscopy provides improved spectral resolution of heterogeneous biological
samples.24 It has been used to study lipid metabolism affected by a variety of diseases, for example cancer,25 diabetes,26 and schizophrenia,27 as
well as cellular processes such as apoptosis.28 Furthermore, the lipid signals observed in HRMAS spectra of intact cells or tissue are from cytosolic
LDs only, rather than lipids associated with membranes. As the dipole-dipole couplings are larger in cell membrane lipids, they are not resolved at
the spinning speeds used in HRMAS 1H NMR spectroscopy.29 This is in contrast to solution state NMR spectroscopy of extracts where all lipid
components are extracted.
In this study, we compare the metabolic response of intact cells treated with two apoptotic agents, cisplatin and etoposide, to that of a con-
trol group. Changes to lipid signals determined using HRMAS and solution state 1H NMR spectroscopy are compared with standard assays for
apoptosis and cell viability. In addition, we use HRMAS and solution-state 1H NMR spectroscopy to study LDs in the control and treated cells and
compare the results with those from fluorescence microscopy. We illustrate the advantages of using HRMAS 1H NMR over solution-state 1H
NMR spectroscopy for the monitoring of apoptosis-related LD formation.
2 | METHODS
2.1 | General
All chemicals, unless otherwise stated, were purchased from Merck (Sigma Aldrich, Dorset, UK).
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2.2 | Cell culture
The C2C12 cell line sub-cloned from a myoblast line established from normal adult C3H mouse leg muscle was cultured in Dulbecco's modified
Eagle's medium (DMEM—D6429) containing 10% foetal bovine serum and 1% PenStrep (100 U mL−1 penicillin + 100 μg mL−1 streptomycin) in a
humidified 5% carbon dioxide atmosphere at 37 C. Cells were grown in T-75 culture flasks with filter-vented caps, seeded at approximately
1.5 × 106 cells per flask. Myogenic differentiation was initiated upon reaching 60% confluence, by switching the cells to medium containing 2%
horse serum supplemented with 1 μM insulin. After 5 days of differentiation, the cells were treated with apoptotic agents: cisplatin (60 μM final
concentration) or etoposide (120 μM final concentration). Dimethyl sulfoxide (DMSO) was used as a vehicle for drugs and the equivalent volume
was added to control cells (1% v/v). The cells were harvested with trypsin after 24 and 48 h incubation, frozen immediately in DMEM + 5%
DMSO and stored at −80 C until use.
2.3 | Cell viability
The trypan blue exclusion test was used to determine the number of viable cells present in cell suspensions before and after NMR experiments.
The test was performed according to a standard cell counting protocol.30 Briefly, 25 μL freshly harvested cells were transferred to a plastic vial
and diluted with phosphate buffered saline (PBS; 1:5 dilution). An equal volume of 0.4% trypan blue dye (Sigma-Aldrich) was added to 8 μL cell
suspension to obtain a 1:2 dilution and mixed by pipetting. The cell-dye mixtures (10 μL) were transferred to Countess cell counting chamber
slides by placing the tip of the pipette at the notch. The viability of cell samples was measured with a Countess automated cell counter
(ThermoFisher Scientific, Hemel Hempstead, UK). The total number of cells was used for normalization of the caspase 3 activity assay. Cell viabil-
ity was expressed as a percentage of live cells. The viability of cells decreases in the MAS rotor by 10% after 3.5 h data acquisition.
2.4 | Caspase 3 assay
Relative apoptosis levels in freshly harvested cell samples were measured using a Caspase 3 assay kit (Ac-DEVD-AMC, BD Pharmingen, San
Diego, CA, USA) following the manufacturer's instructions. Briefly, reaction buffer containing Ac-DEVD-AMC was added to each cell lysate
(106 cells mL−1) and incubated in a black 96-well microplate (Nunc, Thermo Fisher Scientific, Hemel Hempstead, UK) for 1 h at 37 C in the dark.
The fluorescence intensities were measured with a FLUOstar OPTIMA microplate reader (BMG LABTECH) at excitation/emission wavelengths of
380/420 nm.
2.5 | Lipid extraction
Thawed cells (5 × 106 per sample) were washed with 5 mL PBS at room temperature. The metabolites and lipids were extracted simultaneously
using a methanol/chloroform/water extraction method.31 Reagent-grade methanol and chloroform in a ratio of 2:1 (v/v; 500 μL) were added to
each sample and the cells were briefly pulverized with a plastic pipette tip, vortexed and sonicated at room temperature for 1.5 h. Subsequently,
Milli-Q water and chloroform in a ratio of 1:1 (v/v; 500 μL) was added, vortexed and sonicated again for 30 min. The two layers and cell pellet
were separated by centrifuging (7,000 rpm, 7 min) and the lower chloroform fractions containing the cellular lipids were collected into glass vials.
All solvents were then evaporated under a steam of dry nitrogen gas and the lipid fractions re-dissolved in 500 μL of chloroform-d + 0.05% (v/v)
tetramethylsilane (TMS) (Cambridge Isotope Laboratories, Cambridge, MA) for NMR experiments.
2.6 | Solution NMR spectroscopy
1H NMR spectra of lipid fractions from cell extracts were recorded on a Bruker AVANCE II + spectrometer (Bruker, Billerica, MA) operating at a fre-
quency of 500.13 MHz and fitted with a 5 mmTXI probe. One-dimensional high-resolution 1H NMR spectra were acquired at 300 K using a solvent
suppression pulse sequence based on a one-dimensional NOESY pulse sequence (noesypr1d) to saturate the residual 1H water signal. The experi-
ments were run with four dummy scans and 128 acquisition scans with an acquisition time of 4.09 s, relaxation delay 2 s and mixing time of 80 ms.
Total acquisition time was 13 min 48 s. 65.5k data points were recorded across a spectral width of 8012.82 Hz. A line-broadening apodization func-
tion of 0.3 Hz was applied to all 1H NMR free induction decays, which were then pre-processed with an online tool—Workflow4Metabolomics
(W4M) 3.0 (workflow4metabolomics.org).32 Lipid signal assignment was based on the previously reported chemical shifts for similar systems33 and
confirmedwith two-dimensional 1H-1H correlation spectroscopy (COSY) (Supporting Information, Figures S1 and S2).
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For the COSY, a standard Bruker pulse sequence (cosygpprqf) was used. A data matrix of 512 × 4096 points covering 8012 × 8012 Hz was
recorded with 32 scans for each increment and a relaxation delay of 2 s. Spectra were Fourier transformed with sine-bell functions and 0.3 Hz
(F1) and 1 Hz (F2) exponential and 0.1 Hz Gaussian (F1 only) effective line broadening functions applied. All chemical shifts were referenced with
respect toTMS at 0 ppm.
2.7 | High-resolution magic angle spinning NMR (HRMAS NMR) spectroscopy
Thawed cells (5 × 106 per sample) were washed in deuterated PBS. Cell pellets were combined with 10 μL deuterated phosphate-buffered saline
+ 0.05 mM trimethylsilylpropanoic acid (TSP; Cambridge Isotope Laboratories) and packed into 4 mm zirconium oxide rotors with 50 μL Kel-F
inserts (Bruker). All measurements were carried out at 300 K and 5 kHz spinning rate on a 500.13 MHz NMR Bruker AVANCE II+ spectrometer
equipped with a 4 mm HR-MAS probe with a gradient coil allowing gradient pulses up to 34 G cm−1. The temperature was allowed to stabilize for
5 min before acquiring the data. The temperature remained within ±1 K of the set temperature during acquisitions. One-dimensional high-
resolution T2-edited Carr-Purcell-Meiboom-Gill (CPMG)
1H NMR spectra were acquired using pulse sequences with continuous wave solvent
presaturation (cpmgpr1d). All experiments were run with 4 dummy scans and 64 acquisition scans with an acquisition time of 5.45 s and relaxation
delay of 4 s. 65.5k data points were recorded across a spectral width of 6009.615 Hz. For the acquisition of CPMG spectra, total spin-spin relaxa-
tion delay (2nτ) of 40 ms was used, where spin echo number n = 20 and spin echo time τ = 1 ms. Total acquisition time was 10 min 48 s. A line-
broadening apodization function of 1.0 Hz was applied to all HRMAS 1H NMR free induction decays prior to Fourier transformation. All FIDs were
pre-processed with W4M 3.0. Lipid signal assignment was based on literature chemical shifts for similar systems.20,34
Two-dimensional diffusion spectra (diffusion-ordered spectroscopy, DOSY) were recorded using the longitudinal eddy current delay bipolar
gradient pulse sequence (ledbpgp2s)35 with a diffusion delay (Δ) of 0.05 s, a diffusion-encoding pulse width (δ) of 2 ms, echo time of 2.2 ms, and
gradient strengths increasing from b = 124 to 1,571 s mm−2 in 16 linear steps. At each gradient strength, 32 scans and 65.5k data points were
acquired with an acquisition time of 5.45 s, a relaxation delay of 4.0 s, and a line broadening of 1 Hz. The total acquisition time was 1 h 23 min.
Manual phasing and baseline correction was applied before peak-picking in Dynamics Centre (Bruker). All spectra were acquired with constant
receiver gain value and normalized to total spectral integrals.
2.8 | High-gradient diffusion NMR spectroscopy
Thawed cells (1 × 107 per sample) were washed in deuterated PBS. Cell pellets were resuspended in 100 μL PBS containing D2O + 0.05 mM TSP
and packed into 3 mm inserts. All measurements were carried out at 300 K on a Bruker Avance IIIHD 400 MHz NMR spectrometer fitted with a
5 mm Diff50 z-diffusion probe for a wide bore magnet, comprising an actively shielded Z-gradient with strengths up to 50 G cm−1 A−1 (up to
2800 G cm−1). DOSY spectra were recorded using the same pulse sequence and diffusion parameters as for the HRMAS NMR experiments. The
gradient strength was increased from b = 6 to 420 951 s mm−2 in 256 linear steps. For each gradient strength, 32 scans and 50k data points were
acquired with an acquisition time of 5.21 s, a relaxation delay of 0.5 ms, and a line broadening of 1 Hz. Manual phasing and baseline correction
was applied before peak-picking in Dynamics Centre (Bruker).
2.9 | Cell preparation and confocal microscopy imaging
After the apoptotic treatment, the differentiatedmyotubes (5×104 cellsmL−1)were transferred onto35mmglass base collagen-coateddishes (Nunc,
Thermo Fisher Scientific) and left to attach overnight. The samples were incubated with 1 mL staining solution (50 μg mL−1 boron dipyrromethene
(BODIPY) in PBS) for 10min in the dark, washedwith PBS twice before being observed under amicroscope, and photographed. Imageswere acquired
ona LeicaTCSSP8confocalmicroscopeusing a1.3NA,63×oil immersionobjective lens, a scan speedof400Hzanda line averagingof 2.Multichannel
imaging was performed on a 100 μm × 100 μm area (sampled at 1024 × 1024 pixels) using an excitation laser line of 488 nm (emission detection
500-520nm). 2D time-lapse sequenceswere taken every 5 s, resulting in 50-60 images of a 50×50 μm2area (2048×2048pixels).
2.10 | Data analysis
1D 1H NMR spectra were analysed over the spectral region between 0.5 and 8.0 ppm, with the exclusion of the water region (4.5-5.0 ppm), and
normalized to the sum of all peak integrals using MetaboAnalyst v. 4.0 (University of Alberta, Canada).36 The changes in lipid integrals induced on
the treatments are reported as a fold change relative to the control group.
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Diffusion data was fitted using Dynamics Centre v2.5.1 (Bruker). The relative standard deviations of all diffusion fits to exponential decays
were less than 5%. The minimum signal-to-noise ratio for the highest b-values was 21.3 (Supporting Information, Tables S1 and S2). The contribu-
tion of non-lipid metabolites to apparent diffusion coefficients of mobile lipids is excluded by taking advantage of the significant difference
between the apparent diffusion coefficients of lipids and non-lipid metabolites (Supporting Information, Figure S5).
Image analysis and measurements were carried out using the ImageJ software package v. 1.52i (National Institutes of Health, Bethesda, MD,
USA). The results were averaged across 548, 1183, and 560 LDs in control, cisplatin, and etoposide samples, respectively. Time-lapse images were
pre-processed to extract object characteristics and trajectories using standard image processing techniques and tracking algorithms from the
TrackMate plugin (ImageJ).37
Statistical analysis was carried out in Excel (Microsoft, Seattle, WA) or MetaboAnalyst; Student's unpaired t test with equal variance was
used to compare two groups. Analysis of variance (ANOVA) with the post hoc Fisher least significant difference analysis was used when
multiple comparisons were made. Unless otherwise stated, data are presented as mean ± standard error of the mean (SEM) and represent a
biological variance of at least four repeats. False discovery rate adjusted p values less than 0.05 were considered significant. For curve and
line fitting, partial least-square regression was used. Mean square displacement analysis was based on NMR diffusion data and calculated from
the following equation: <x>2 = 2Dτ, where <x>2 is the mean square displacement, D the diffusion rate measured by NMR, and t the diffusion
time (50 ms).
3 | RESULTS AND DISCUSSION
3.1 | LD concentration determined by NMR spectroscopy and the link to apoptosis
C2C12 mouse myotubes were subjected to two apoptosis-based treatments commonly used in cancer therapies: cisplatin or etoposide. We com-
pared 1H HRMAS NMR spectroscopy analysis of lipids in intact cells with solution-state 1H NMR of lipid extracts from the whole cells after incu-
bation for 48 h. The HRMAS spectrum of intact cells represents total NMR-detectible metabolites with relatively fast tumbling rates, and for
example included resonances from glucose, lactate, creatine, and lipids. Solution-state 1H NMR of lipid extracts, on the other hand, represent all
extracted lipids including membrane lipids, which are not visible in the HRMAS 1H NMR spectra. Figure 1A and 1B shows NMR spectra of intact
cells and the hydrophobic (lipid) fraction of cell extracts. We assigned lipid signals in control and treated samples, and compared lipid content
across the two NMR techniques. Figure 1C-F shows the results for -CH3 and -HC=CH- resonances.
Both NMR methods showed a significant increase in lipid -CH3 signal intensities for apoptotic cells. The HRMAS
1H NMR spectrum showed
a 100% increase in the intensity of the lipid -CH3 signal, whereas solution
1H NMR showed only a 10% increase. Unsaturated lipids increased by
100% following etoposide treatment in HRMAS NMR spectroscopy spectra and by 50% in solution-state NMR, but no change was seen for cis-
platin treated cells by solution state NMR. The data showed that the increase of NMR-visible lipids during apoptosis is larger as detected by
HRMAS 1H NMR spectroscopy. This discrepancy between cell extract and intact cell samples suggests two processes may be occurring to induce
these lipid changes: (1) a modest increase in de novo lipogenesis, which is detected by both solution state and HRMAS 1H NMR spectroscopy;
and (2) a larger effect associated with changes in the biophysical properties of NMR-observable lipids, which may be associated with portioning
of lipids from the cell membrane to LDs and/or changes in LD size. Both processes may affect the tumbling rate of lipids, increasing the NMR visi-
bility of the resonances associated with fatty acids.
Solution-state NMR spectra of whole cell extracts represent the collective signal from cytosolic LDs, membrane lipids, and lipids contained
within cell organelles. The change in LD-associated lipid concentration is ‘masked’ due to opposing changes in phospholipids during apoptosis.
Cells undergoing apoptosis are characterized not only by increased mobile lipid profiles, but also by decreased phosphatidylcholine and total phos-
pholipid concentration as reported by Gibbons and colleagues.38,39 In order to determine changes in mobile lipids using a solution NMR approach,
LDs need to be isolated first. This is a time and labour expensive process and not all lipids may be extracted. The data suggest that HRMAS NMR
offers an improved way to monitor changes in mobile lipid concentration in intact cells as it is more selective.
Cellular and biochemical changes during apoptosis can also contribute to the increases in NMR-visible lipids in intact cells. Quintero and col-
leagues reported an increase in NMR-visible lipids during cell proliferation but no absolute increase in neutral lipids, and proposed an increased
transport of TAG as a possible explanation.40 It is also possible that cytoskeletal remodelling during apoptosis leads to increased LD mobility,
which makes them more NMR visible.41
In order to confirm the level of apoptosis in the control and treated cells they were tested after 8, 24, and 48 h incubation using the
caspase 3 assay. Figure 2A shows the fold change during apoptosis relative to the control group for different incubation periods. The sam-
ples incubated with cisplatin and etoposide for 24 h and 48 h exhibited significantly higher levels of apoptosis compared with the control
group. Figure 2B shows a positive correlation between apoptosis levels and the NMR-visible lipid signal in intact cells (R2 = 0.86 for pooled
samples, n = 36). This is consistent with the previous reports of LDs as a biomarker for apoptosis3,7 and confirms apoptosis-related lipid
accumulation.
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3.2 | Determination of apparent diffusion of mobile lipids in intact cells by HRMAS NMR
The increased lipid signal intensities observed in the NMR spectra can be associated with either the formation of larger LDs or a higher number of
small LDs. We measured apparent diffusion coefficients of mobile lipids by DOSY under HRMAS to discriminate between these two scenarios.
The apparent diffusion coefficients of the five lipid signals and choline-containing compounds assigned in Figure 1 are shown inTable 1.
F IGURE 1 Comparison of metabolic profiles of intact cells recorded by HRMAS 1H NMR and cell extracts recorded by solution 1H NMR
spectroscopy. A, Representative 1D 1H NMR spectra of intact cells in PBS containing D2O + 0.05 mM TSP; B, hydrophobic fraction of cell
extracts in chloroform-d + 0.05% v/v TMS. Lipid signals were assigned based on literature values and COSY 1H-1H experiments. WSM, water-
soluble metabolites; Chol, choline compounds. C-F, The fold changes in -CH3 and -HC=CH- lipid signal intensities are shown as box and whisker
plots for intact cells (C, E) and cell extracts (D, F) for control (green), cisplatin (red) and etoposide (blue) treated cells for 48 h. The boxes show
median concentrations and the 25th and 75th percentiles; the whiskers indicate minimum and maximum concentrations. Data normalized to total
spectral intensity. **p < 0.01, ***p < 0.001, n = 4
F IGURE 2 Apoptosis in cultured mouse C2C12 myotubes exposed to cisplatin, and etoposide for 8 h, 24 h, and 48 h compared with the
control group. A, Fold change in apoptosis relative to the control group measured with the caspase 3 fluorometric assay. *p < 0.05, **p < 0.01,
***p < 0.001. B, The correlation between apoptosis level and NMR lipid signal for the control and treated samples at 8 h, 24 h, and 48 h. Error
bars indicate standard error, n = 4
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In order to highlight the differences between control and treated samples we analysed the diffusion data using principal component analysis
(PCA) (Figure 3A) and ANOVA (Figure 3B).
The diffusion data derived from DOSY NMR experiments were subjected to multivariate statistical analysis in MetaboAnalyst. PCA was used
to observe inherent clustering and to discriminate the variables that are responsible for variation between the groups (Figure 3A). Group separa-
tion along principal component 1 (PC1) accounted for 67.3% of total variation and PC2 accounted for 24.2%. Three apparent diffusion coeffi-
cients showed significant discriminative power between control and cisplatin samples: -CH2-, -HC=CHCH2-, and -COCH2-. The cisplatin group
was characterized by the decreased apparent diffusion coefficients of lipids. The apparent diffusion coefficients measured for the etoposide sam-
ples also showed a decreasing trend, albeit not significant.
An ANOVA analysis allows us to highlight differences between cisplatin, etoposide, and control samples. In the cisplatin treated samples, the
-CH2-, -HC=CHCH2-, and -COCH2- signals gave significantly lower rates (Figure 3B). Griffin and colleagues have previously reported values for
apparent diffusion rates of lipids in intact endometrial cells measured by HRMAS 1H NMR spectroscopy.20 The comparison of the apparent diffu-
sion rates is shown in Table 2. Those for -CH3, -CH2-, and choline compounds showed good agreement, whereas those for -HC=CHCH2-,
-COCH2-, and -HC=CH- are much higher in endometrial cells. This may be due to overlap of different peaks in the NMR spectrum and differences
in metabolic profiles of different cell lines.
The content and concentration of small metabolites and lipids vary from cell line to cell line. The NMR region of 2.0-2.5 ppm, which corre-
sponds to -HC=CHCH2- and -COCH2- lipid signals, is crowded with peaks from other small metabolites such as acetyl groups and glutamate,
which diffuse much faster. The contribution of these metabolites results in higher apparent diffusion rates for lipids and it is important to exclude
TABLE 1 Mean diffusion coefficients
of selected lipid signals for control,
cisplatin-, and etoposide-treated samples
after 48 h. Control and cisplatin n = 8,
etoposide n = 4. Statistical significance
was determined with ANOVA, *p < 0.05.
The apparent diffusion coefficient values
were measured at a diffusion time of
50 ms. ± values refer to standard error
Lipid peak Control [μm2 s−1] Cisplatin [μm2 s−1] Etoposide [μm2 s−1]
-CH3 148.1 ± 22.4 72.2 ± 9.1 113.2 ± 22.2
-CH2- 120.1 ± 14.0 67.4 ± 8.6* 102.6 ± 18.1
-HC=CHCH2- 125.2 ± 7.1 76.1 ± 8.3* 104.5 ± 21.9
-COCH2- 125.4 ± 7.9 71.5 ± 8.5* 103.4 ± 21.5
-HC=CH-a 91.1 ± 27.4 69.5 ± 8.7 117.1 ± 44.6
choline 164.7 ± 12.1 217.3 ± 22.2 146.3 ± 21.8
aThe proximity of the HC=CH lipid signal to the water signal means that the optimization of water
suppression is crucial to obtain accurate and reproducible values for this signal.
F IGURE 3 Statistical analysis of NMR-based diffusion data of intact cells: control (♦, green), cisplatin (■, red), and etoposide (●, blue). A,
Two-dimensional PCA score plot derived from the diffusion rates of six lipid species. Each data point represents one sample. B, Box and whisker
plots comparing apparent diffusion coefficients (ADCs) for each lipid signal across control, cisplatin, and etoposide. The box covers the 25th and
75th percentiles, the line in the box represents the median value, the cross represents mean and the whiskers indicate minimum and maximum
values. Outliers are shown as points. Significant perturbation assessed by ANOVA: *p < 0.05
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them. This was achieved by starting the diffusion experiment at a non-zero gradient value (b = 124 s mm−2). Moreover, the chemical groups under
investigation belong to a series of different fatty acids, which in turn can be on different lipids, eg FFAs, TAGs, and phosphocholines, and these
will have different mobilities. NMR DOSY spectroscopy measures an average apparent diffusion coefficient across the whole ensemble.
Apparent diffusion coefficients of mobile lipids have also been measured ex vivo by 1H MRS.18 Remy et al reported two values of apparent
diffusion coefficients for mobile lipids in rat glioma: 46 ± 17 μm2 s−1 for the mean LD radius of 0.485 μm and 11.0 μm2 s−1 for an equivalent
spherical diameter of 4.27 ± 0.71 μm.42 The discrepancy between these two measurements was explained by differences in the range of gradient
strengths and differences in tumour growth. The higher value was measured with b = 0-8000 s mm−2 and the slower rate with
b = 0-50 000 s mm−2. Our apparent diffusion rates from intact cells are expected to be faster because of the structure of the samples (cell versus
tissue) and relatively low gradient strengths used (b = 124-1571 s mm−2). In order to explore this large difference in apparent diffusion rates we
have investigated a wider range of gradient strengths than has been used previously.
We have investigated the impact of gradient strength using a high gradient diffusion probe (Diff50, b = 6-420 951 s mm−2). A larger range of
gradient strengths enables us to better investigate lipids diffusing at slower rates. Figure 4 shows a Stejskal-Tanner plot generated using this wide
range gradient approach.43 We explored fitting the data to single- and biexponential models but neither described the data satisfactorily. The solid
line presented in Figure 4 shows the fit using a three-component model, which provided the best fit to the diffusion data. The fastest apparent
diffusion rate measured using the high-gradient-strength probe is similar to the apparent diffusion coefficients measured by HRMAS NMR. The
apparent diffusion values for the -CH2 lipid signal are 120.1 μm2 s−1 and 175.8 μm2 s−1 as measured with the HRMAS probe and the Diff50
probe, respectively. Using the higher gradient strength, we are now able to resolve two other lipid species with apparent diffusion rates of
41.7 μm2 s−1 and 0.582 μm2 s−1.
We compared apparent diffusion rates of lipids in intact cells measured using HRMAS and solution-state NMR. These measurements show
that HRMAS NMR and solution diffusion measurements give similar results regardless of sample packing (rotor versus 3 mm tube) and experimen-
tal conditions (spinning versus no spinning). In addition, there are lipids diffusing more slowly in intact cells, which cannot be studied with standard
TABLE 2 Mean apparent diffusion coefficients of selected lipid signals for untreated muscle cells and endometrial cells as reported by Griffin
et al and for rat glioma tissue by Remy et al. ± values refer to standard error, *value corresponds to restricted diffusion
Lipid peak C2C12 muscle cells [μm2 s−1] Endometrial cells20 [μm2 s−1] Rat glioma tissue18 [μm2 s−1]
-CH3 148.1 ± 22.4 200 ± 10
-CH2- 120.1 ± 14.0 200 ± 10 46 ± 17*
-HC=CHCH2- 125.2 ± 7.1 600 ± 40
-COCH2- 125.4 ± 7.9 800 ± 50
-HC=CH- 91.1 ± 27.4 500 ± 30
Choline 164.7 ± 12.1 200 ± 10
F IGURE 4 A triexponential diffusion fit for the CH2 signal displayed as a Stejskal-Tanner plot. Diffusion data collected for untreated cells
packed in 3 mm tubes using a high gradient 5 mm probe (Diff50). Error bars correspond to the line fitting errors
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NMR probes. Slower moving lipid species may correspond to lipids located in different cellular environments (for example, the viscosity and
molecular crowding is different in nucleus and cytoplasm44–46) or even in lipid rafts, where the movement of lipids is highly restricted.47 This
approach opens up new opportunities for investigating lipid behaviour in intact cells.
3.3 | Microscopy compared with HRMAS 1H NMR spectroscopy of mobile lipids
The standard approach for measuring the size of LDs in intact cells is fluorescence microscopy. Figure 5A-C shows images of labelled LDs in con-
trol and treated cells. The size of LDs was determined by image analysis.
The analysis of the LD populations showed that the average LD cross sectional areas was 0.26 ± 0.03 μm2, 0.40 ± 0.03 μm2, and
0.36 ± 0.04 μm2 in the control, cisplatin, and etoposide-treated samples, respectively. Of these, only the size of LD in cisplatin samples was con-
firmed to be statistically significant for the group differentiation over all samples (p = 0.04, ANOVA).
We compared HRMAS 1H NMR-based diffusion coefficients with the size of LDs measured by fluorescence confocal microscopy. LD size is








where D is the diffusion constant [m2s−1], k Boltzmann's constant [m2kgs−2K−1], T temperature [K], v viscosity [kgm−1s−1], and r the radius of
the diffusing particle [m].
Figure 5D shows a plot of the apparent diffusion coefficients determined by HRMAS NMR against LD size from microscopy. The apparent
diffusion coefficients for the individual lipid signals, -CH3, -CH2-, -HC=CHCH2-, -COCH2-, and -HC=CH- (Table 1), correlated with the mean LD
F IGURE 5 Correlation of microscopy-based LD size estimates and HRMAS 1H NMR-based mean apparent diffusion coefficients. A-C,
Representative images of fluorescence labelled LDs in a single cell: A, control; B, cisplatin treatment; C, etoposide treatment. Arrows indicate
neutral lipids in LD stained with BODIPY dye. Images were taken after 48 h incubation. D, Regression analysis for mean LD size and NMR-based
diffusion rates for control, cisplatin, and etoposide samples at 24 h (●) and 48 h (▲) incubation times. Four dots aligned vertically represent four
chemical groups (CH3, CH2, COCH2, CH=CHCH2, also shown in Supporting Information, Figure S3). The graph represents the collective apparent
diffusion coefficient from each chemical group. Error bars indicate the standard error. Separate regression fits for the two incubation times are
shown (R2 = 0.897 for 24 h and R2 = 0.921 for 48 h)
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area. The experimental data from the 24 h and 48 h time points were fitted using two separate regression models. In both cases the data are
highly correlated (R2 = 0.90 for 24 h and R2 = 0.92 for 48 h)
From Figure 5D we can see that the apparent diffusion coefficients from HRMAS NMR correlate well with LD size estimated by microscopy.
The results illustrate that NMR-based diffusion measurements can differentiate between normal and apoptotic cells and could therefore have
potential application in monitoring LD size during apoptotic-based treatments in intact cells.
3.4 | Viscosity of cytoplasm
Since LD size by microscopy and mobile lipid diffusion by NMR spectroscopy were highly correlated, we investigated if combining the HRMAS 1H
NMR diffusion data and fluorescence microscopy measurements would lead to correct estimation of the cytoplasmic viscosity. If we assume that
LDs are ideal spheres, a constant temperature (300 K), and no cytoplasmic changes due to treatments, we can deduce the viscosity from the mod-








where b is a constant [m2s−1].
The viscosity can be determined from the slope of the graph of D~1r . Using data described in Figure 5D, we calculated cytoplasmic viscosity.
The values obtained for each lipid signal and their average are listed in Table 3 and the D~1r graphs for each lipid signal are in the Supporting
Information.
The intracellular viscosity values reported in various cell lines and by different methods vary widely: 0.75-18 mPa s at 300 K.49 Our viscosity
values calculated based on NMR diffusion data are in agreement with values from Ye et al, who reported the viscosity of cytosol as
1.7-2.55 mPa s measured by 19F NMR spectroscopy.48 Moreover, the viscosity calculated for cells incubated for 24 h is significantly different
from the viscosity of cells incubated for 48 h (p = 0.01). The different values of viscosity for 24 h and 48 h samples may be explained by cytoplas-
mic changes during cell maturation/cell growth. Changes in the cytoplasmic viscosity have been reported during germination50; and the cytoplasm
viscosity is sensitive to changes in concentration of Ca2+, Mg2+, and ATP.51 This suggests that, HRMAS NMR-based diffusion measurements may
be able to detect not only changes in mobile lipids but also changes in cytosol viscosity. Further experiments are also needed to understand the
impact of the freeze-thaw cycle on cytosolic viscosity.
3.5 | Determination of mean displacement
In addition to measuring LD size by microscopy we also tracked the movement of individual LDs in intact cells for the control and cisplatin
samples. By tracking individual LDs, we were able to calculate mean square displacement and compare it with the value determined by
HRMAS 1H NMR diffusion measurements. Equation 3 describes the relationship between one dimensional diffusion and mean square
displacement.52
< r > 2 =2Dt: ð3Þ
Figure 6A shows a comparison between LD mean displacement values calculated from NMR diffusion data and mean displacements mea-
sured by microscopy tracking. Both the microscopy-based and NMR-based mean square displacements were shorter for cisplatin than for the
control group, which is consistent with larger LDs that diffuse more slowly. However, the microscopy-based mean displacements were shorter
than the NMR-based mean displacements.
TABLE 3 The viscosity (v) of cytoplasm calculated from HRMAS 1H NMR diffusion data and fluorescence microscopy for cells at 24 h and
48 h incubation time points. For comparison, we included values of cytoplasm viscosity measured using T1 relaxation times of
19F-labelled
proteins in cells by 19F NMR spectroscopy48





Average 1.74 ± 0.13 2.93 ± 0.24 1.7-2.55
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It is interesting to discuss the discrepancy between the results, as the two methods have different spatial and temporal detection limits. The
spatial resolution of the microscopy used here allows monitoring of apparent LD diffusion.53 Conversely, HRMAS NMR-based diffusion experi-
ments in our study describe mobility of LD-associated lipid molecules. Therefore, apparent diffusion coefficients and hence mean displacements
measured by the two methods correspond to different biological processes: microscopy captures decreased apparent diffusion rates in apoptotic
cells due to larger LDs, and HRMAS NMR spectroscopy most likely captures decreased apparent diffusion rates of mobile lipids, which can be
linked to the more crowded environment within larger LDs.
Our results are in contrast to the study by Pérez and colleagues, who reported similar sizes of LDs obtained from microscopy and NMR exper-
iments.17 Following the same approach (diameter = mean displacement × √10), we calculated the mobile lipid compartment sizes based on NMR
mean displacement and obtained the values of 5.9 μm and 4.22 μm for control and cisplatin, respectively. The results suggest that our NMR
experiment does not measure the changes in LD size per se, but the changes in mobility of lipids within LDs.
In addition, other subcellular organelles can contribute to the NMR-based mean square displacement values, such as small endosomes. Mar-
tín-Sitjar and colleagues reported that increasing MAS spinning rate resulted in reversible increased in the NMR-visible lipid resonances, and
attributed this to the fatty acyl chains of phospholipids in intracellular endosomes.54 Indeed, we also detected an increase in the choline-
containing compounds (3.21-3.28 ppm, Supporting Information, Figure S4), which supported endosomal phospholipid detection by HRMAS NMR
spectroscopy. The viability of cells decreased in the MAS rotor by 10% after the data acquisition, while this is not the case during the micros-
copy experiment. This could be another potential explanation for the discrepancy.
From a temporal perspective, NMR measures diffusion on a millisecond time scale (50 ms), while microscopy measures diffusion on a second
time scale (5-6 s). This difference in observation time means that NMR-based diffusion measurements may be less sensitive to restricted diffusion.
We tested if NMR-based diffusion rates correspond to free or restricted diffusion by running variable diffusion time NMR experiments over the
range of 50-700 ms. The results in Figure 6B show that the apparent diffusion coefficients of mobile lipids in both control and treated cells
decrease with increasing diffusion time, which is characteristic for restricted diffusion.55 The data are described well by single-exponential fits.
For free diffusion we expect a constant value of diffusion coefficients regardless of diffusion time.56 For the diffusion data presented in Figure 6A
the diffusion time was 50 ms. During this time, lipid molecules travel an average distance of 3.5 μm (Equation 3), and are prone to collisions with
the compartment boundary and collisions with other molecules. While there is a clear difference in LDs between control and apoptotic samples
regardless of analytical method used, more experiments are needed to investigate the reasons for the relationship between the size of LDs and
NMR-based diffusion measurements.
3.6 | Conclusions
HRMAS 1H NMR spectroscopy showed differences in the lipid profiles of control cells and those treated with cisplatin and etoposide. The con-
centration of NMR-visible lipids increases on treatment and it correlates well with the degree of apoptosis as measured by the caspase assay. Dif-
fusion data showed significant decrease in apparent diffusion rates of NMR-visible lipids at 50 ms diffusion time upon apoptosis, and this
correlated well with an increase in LD size measured with fluorescence microscopy. High-gradient-strength diffusion experiments revealed a
broader range of diffusion environments than are seen by standard techniques. Microscopy and NMR spectroscopy-based mean displacements
are shorter for cisplatin-treated cells compared with controls.
F IGURE 6 A, Mean and SEM values of LD displacement calculated from HRMAS 1H NMR diffusion data and confocal fluorescence
microscopy. B, Apparent diffusion coefficients of LDs in intact cells as a function of diffusion time. Data correspond to control (♦, green) and
cisplatin (■, red) treated cells at 24 h. Error bars correspond to standard errors; asterisks represents statistical significance: *p < 0.05, ***p < 0.001
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HRMAS NMR spectroscopy offers a label-free approach for monitoring changes in lipid behaviour during apoptosis, and could provide a mini-
mally invasive technique for monitoring this molecular event in vitro and in vivo.
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